# The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid

> **NCT00001191** · PHASE2 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)**

## Conditions studied

- Gastrinoma
- Zollinger Ellison Syndrome

## Interventions

- **DRUG:** Pantoprazole
- **DRUG:** Omeprazole

## Key facts

- **NCT ID:** NCT00001191
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1983-02-03
- **Primary completion:** —
- **Final completion:** 2007-12-10
- **Target enrollment:** — (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001191, "The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00001191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*